diagnosis, prognosis, and therapy of true et vs. prefibrotic mf
Published 9 years ago • 2.4K plays • Length 18:09Download video MP4
Download video MP3
Similar videos
-
21:26
the who updated diagnostic criteria for et, pv & mf
-
18:36
diagnostic challenges in mpn
-
21:29
topical challenges in the management of et
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
23:34
is there a role for jak inhibitors in essential thrombocythemia (et)?
-
25:48
the who updated diagnostic criteria for mpn
-
23:17
mutations in myelofibrosis: which to test for, when and why
-
12:24
development of long-acting interferon as new therapy for pv and et
-
0:48
the diagnostic evaluation of hereditary and acquired neuromuscular diseases
-
6:35
goodpasture syndrome - causes, symptoms, diagnosis, treatment, pathology
-
17:25
molecular prognostication in essential thrombocythemia and polycythemia vera: does it matter?
-
2:20
mthfr testing
-
20:03
my approach to mf management
-
5:45
'truly remarkable' drug can reverse decline caused by motor neurone disease - bbc news
-
10:33
debate: should we treat early-stage myelofibrosis? - no, only observe
-
24:12
debate: survival benefit of jak2 inhibitors in myelofibrosis
-
13:49
“masked” polycythemia vera and polycythemia vera “in evolution”
-
0:22
myelofibrosis symptoms (pre-diagnosis)